| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | +15.02% | +0.14% | +14.89% | +8.23% | — |
| 14d | 3 | +66.67% | +15.59% | -0.83% | +16.43% | +24.79% | — |
| 30d | 3 | +66.67% | +13.34% | +2.33% | +11.01% | +21.13% | — |
| 60d | 3 | +66.67% | +58.23% | +7.63% | +50.60% | +23.47% | — |
| 90d | 3 | +100.00% | +111.18% | +9.62% | +101.57% | +74.48% | — |
| 180d | 3(1 pending) | +50.00% | +4.63% | +14.08% | -9.44% | -9.44% | — |
| 1y | 3(2 pending) | +100.00% | +11.69% | +33.67% | -21.98% | -21.98% | — |
| 2y | 3(2 pending) | +0.00% | -80.67% | +8.63% | -89.30% | -89.30% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ABSI ABSCI CORP | PURCHASE Chief Innovation Officer | 100,000 | $2.29 | $229.0K | 421,446 | Mar 12, 2026 | Mar 16, 2026 ↗ | View → |
| ABSI ABSCI CORP | SALE Chief Innovation Officer | 1,257 | $2.80 | $3.5K | 321,446 | Mar 3, 2026 | Mar 4, 2026 ↗ | View → |
| ABSI ABSCI CORP | SALE Chief Innovation Officer | 1,469 | $2.99 | $4.4K | 322,703 | Feb 3, 2026 | Feb 3, 2026 ↗ | View → |
| ABSI ABSCI CORP | SALE Chief Innovation Officer | 3,092 | $3.68 | $11.4K | 324,172 | Oct 14, 2025 | Oct 14, 2025 ↗ | View → |
| ABSI ABSCI CORP | PURCHASE Chief Innovation Officer | 50,000 | $3.04 | $152.0K | 327,264 | Jul 28, 2025 | Jul 28, 2025 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 23,700 | — | — | 277,264 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 93,700 | — | — | 93,700 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| ABSI ABSCI CORP | SALE Chief Innovation Officer | 1,469 | $3.71 | $5.4K | 253,564 | Feb 1, 2025 | Feb 4, 2025 ↗ | View → |
| ABSI ABSCI CORP | SALE Chief Innovation Officer | 3,092 | $4.07 | $12.6K | 255,033 | Oct 12, 2024 | Oct 16, 2024 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 349,625 | — | — | 349,625 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 83,125 | — | — | 258,125 | Feb 1, 2024 | Feb 5, 2024 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 175,000 | — | — | 175,000 | Oct 12, 2023 | Oct 16, 2023 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 550,000 | — | — | 550,000 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 2,000,009 | — | — | 2,000,009 | Oct 3, 2022 | Oct 5, 2022 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 4,783 | — | — | 4,783 | Jun 8, 2022 | Jun 10, 2022 ↗ | View → |
| ABSI ABSCI CORP | PURCHASEGRANT Stock grant | 45,180 | — | — | 45,180 | Mar 17, 2022 | Mar 21, 2022 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 135,000 | — | — | 135,000 | Jan 20, 2022 | Jan 24, 2022 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Dec 9, 2021 | Dec 10, 2021 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASE Chief Innovation Officer | 125,000 | $2.53 | $316.3K | 254,704 | Nov 9, 2020 | Nov 12, 2020 ↗ | View → |
| CYCN CYCLERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Nov 4, 2020 | Nov 6, 2020 ↗ | View → |